HIGHLIGHTS
- who: Philipp E. Hartrampf from the Department of Nuclear Medicine, University Hospital Germany have published the Article: Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [, in the Journal: (JOURNAL)
- what: In this study that included 92 patients, the authors aimed to expand the current literature on u00ad[177Lu]Lu-PSMA I and amp;T and to identify predictive baseline characteristics, focusing on long-term follow-up. with a follow-up period of at least 18 months after commencing the first treatment cycle were included. Given the exploratory design of the study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.